Condition AZ: g

Background

Galactosaemia is a rare genetic disorder that can cause a severe life-threatening illness in babies fed with breast milk or standard formula milks. In addition some long-term problems occur in most children even with treatment.

Credits

Last updated March 2019 by Dr Elisabeth Jameson, Consultant Paediatrician, Inherited Metabolic Disease, Willink Biochemical Genetics Unit, Genetic Medicine, Manchester Academic Health Science Centre, Manchester, UK.

Although great care has been taken in the compilation and preparation of all entries to ensure accuracy, we cannot accept responsibility for any errors or omissions. Any medical information provided is for education/information purposes and is not designed to replace medical advice by a qualified medical professional.

What are the symptoms?

Babies with galactosaemia become unwell in the first few days or weeks after birth. Symptoms include:

  • feeding difficulties
  • vomiting
  • jaundice (yellowing of the skin and the whites of the eyes due to build-up of a substance called bilirubin)
  • liver and kidney disease
  • cataracts
  • poor weight gain

If the disorder is not treated promptly there is a risk of death due to liver failure, bleeding or infection.

Older children, even with treatment, usually have some difficulties with learning and speech development. Most girls with galactosaemia have a delay in their pubertal development and as women are infertile.

What are the causes?

Human milk and milk from other animals contains the sugar galactose. This sugar must be changed into glucose for it to be used by the body. In classical galactosaemia the GALT enzyme, that is necessary for doing this is not made correctly. Galactose and other substances increase in the body causing the illness.

How is it diagnosed?

In some countries (not the UK) galactosaemia is looked for in blood from the new born heel prick test. In the UK, the diagnosis is generally made by investigating babies who become unwell. The diagnosis can be made by a simple blood test of the GALT enzyme.

How is it treated?

Breast or standard formula milk should be stopped in any baby suspected of having galactosaemia. Once this is done, the symptoms of severe liver and kidney problems usually resolve. Soya or other special milk formulas can be given as these do not contain galactose.

In children who have been weaned off milk, other products containing galactose must be excluded from the diet. These are generally dairy products such as cheese and yoghurt.

Girls with galactosaemia will usually require hormone treatment in order to proceed into puberty. This will be managed by a specialist doctor called an endocrinologist and a referral will be made once the girl reaches about 10 years of age.

Inheritance patterns and prenatal diagnosis

Inheritance patterns
Galactosaemia is an autosomal recessive, inherited condition and so is life-long. The parents of children with galactosaemia will each  have one normal and one abnormal gene that makes the GALT enzyme. One normal gene makes enough enzyme so that parents do not have the disorder themselves. However, at the time of conception there is a 1 in 4 chance or 25% chance their baby will have inherited both the abnormal genes from his/her parents. He/she is then unable to make the GALT enzyme and as a consequence has galactosaemia. If a baby is at risk he/she will be tested at birth and started on a galactose free formula while the result is awaited. Affected families should be referred to a genetics centre for advice and support.

Prenatal diagnosis
This is possible by chorionic villus sampling at ten to 12 weeks with amniocentesis at 16 weeks if necessary.

Is there support?

Galactosaemia Support Group

Tel: 0121 378 5143
Email: [email protected]
Website: galactosaemia.org

The Group is a Registered Charity in England and Wales No. 1020167. It provides information and support to anyone affected by galactosaemia, and puts families in contact with each other. 

Group details last updated March 2019.

As galactosaemia is a metabolic disease, information and advice are also available from Metabolic Support UK (see entry Inherited Metabolic diseases).

Also known as: Glomerular Nephritis

Background

Glomerulonephritis, inflammation of the glomeruli (small filtering structures in the kidney) is an umbrella name for a range of conditions generally caused by an abnormality in the immune system, which is triggered for unknown reasons.

Glomerulonephritis is one of the major causes of renal failure, and the main cause of kidney disease in young adults. It is estimated that 20 per cent of those on dialysis have glomerulonephritis.

Credits

Medical text written February 2003 by Contact a Family. Approved February 2003 by the Medical Advisor (Consultant Nephrologist) of the National Kidney Research Fund, UK. Last updated February 2010 by David Goldsmith, Consultant Kidney Physician, Guy’s Hospital, London, UK.

What are the symptoms?

People with glomerulonephritis may have some or all of the following symptoms: haematuria (blood in the urine), proteinuria (protein in the urine), swelling in parts of the body due to water and salt retention, progressive or chronic renal failure and high blood pressure (hypertension). Existing treatment consists of careful control of all these symptoms, especially blood pressure.

The identification of the specific form of glomerulonephritis in an individual will depend on the results of a kidney biopsy:

  • minimal change disease, one of the causes of nephrotic syndrome does not lead to renal failure and is common in children
  • focal and segmental glomerulosclerosis includes nephrotic syndrome, hypertension and renal failure, and is commoner in young adults
  • membranous nephropathy is characterised by proteinuria or nephrotic syndrome, renal failure, and is common in middle age
  • immunoglobulin A (IgA) nephropathy is the commonest form of glomerulonephritis and manifests with proteinuria, hypertension and slow renal failure. It mainly affects young adults
  • acute diffuse glomerulonephritis, which usually follows infection, tends to resolve and is now rare in Western countries. It is characterised by haematuria/proteinuria and hypertension leading to acute nephritis
  • the rare crescentic glomerulonephritis leads to rapid renal failure and is more common in middle age/older patients.

What are the causes?

The glomerular filters in the kidney take blood under pressure and filter out excess water, waste products and some salts. These filters sometimes become inflamed and enlarged, usually due to the white blood cells in the body’s immune system turning against the body. This causes the inflammation. The underlying mechanism of disease is not well understood and is the subject of much current research. This inflammation can develop at any time and an occurrence may be triggered by an event such as an infection in a person with a genetic susceptibility to the disease. Glomerulonephritis can be caused by systemic diseases, such as lupus and rheumatoid arthritis.

It is unknown why the inflammation of the kidneys gets better in some people once treatment starts while in others the kidneys develop a scarring process and continue to decline.

How is it treated?

A variety of drugs are used to get the balance right and this differs from person to person. In some cases, the use of non-specific drugs which affect the immune system (eg steroids) may help. In all cases the aim of treatment is to prevent the kidneys completely failing to function. If kidney failure takes place, individuals will need dialysis or transplantation.

Is there support?

Information and support in the UK for glomerulonephritis is provided by the Kidney Research UK (see entry Kidney disease).